Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
PEOPLES FINANCIAL CORP /MS/Peoples Financial Corporation Reports Significant Decline in Q3 2025 Net Income
MNTN, Inc.MNTN Reports 22.6% Revenue Growth to $70M in Q3 2025
PEOPLES FINANCIAL SERVICES CORP.Peoples Financial Services Corp. Reports $15.2M Net Income Turnaround in Q3 2025
Hashdex Nasdaq CME Crypto Index ETFHashdex Nasdaq Crypto Index US ETF Reports First Quarter Financial Performance
AMERICAN VANGUARD CORPAmerican Vanguard Reports Modest Sales Increase and Continued Net Losses in Q3 2025
Septerna, Inc.Septerna Reports $21.5 Million Revenue for Q3 2025, Achieves Net Income of $8.2 Million
Bark, Inc.Bark, Inc. Reports 15.2% Revenue Decline and Increased Net Loss in Q2 Fiscal 2026
SONIDA SENIOR LIVING, INC.Sonida Senior Living Reports 31.2% Revenue Growth in Q3 2025, Faces Increased Net Loss
GIFTIFY, INC.Giftify Reports Revenue Decline in Q3 2025, Despite Increased Gross Profit
CHOICEONE FINANCIAL SERVICES INCChoiceOne Financial Services Reports Significant Growth Following Fentura Merger
MDU RESOURCES GROUP INCMDU Resources Group Reports 9% Revenue Increase in Q3 2025, Net Income Declines
OptimumBank Holdings, Inc.OptimumBank Holdings Reports Significant Financial Growth with $1.08 Billion in Assets
Envoy Medical, Inc.Envoy Medical Reports 25% Revenue Decline and Increased Operating Loss in Q3 2025
Athene Holding Ltd.Athene Holding Ltd. Reports 22.6% Revenue Growth to $7.998 Billion in Q3 2025
4D Molecular Therapeutics, Inc.4D Molecular Therapeutics Reports $56.9 Million Net Loss in Q3 2025
CRISPR Therapeutics AGCRISPR Therapeutics Reports Q3 2025 Revenue Increase to $889,602 Amid Rising Net Loss
Jasper Therapeutics, Inc.Jasper Therapeutics Reports $18.7 Million Net Loss in Q3 2025 Amid Rising R&D Expenses
Biohaven Ltd.Biohaven Reports $173.4 Million Net Loss in Q3 2025, Decreases Operating Expenses
Protara Therapeutics, Inc.Protara Therapeutics Reports $13.3 Million Net Loss in Q3 2025, Sees Increased Operating Expenses
Organon & Co.Organon & Co. Reports Q3 2025 Financial Results with $1.602 Billion Revenue
ENVIRI CorpEnviri Corporation Reports Q3 2025 Financial Results with Revenue Increase and Net Loss
Voyager Therapeutics, Inc.Voyager Therapeutics Reports Significant Revenue Decline and Increased Losses in Q3 2025
Dominari Holdings Inc.Dominari Holdings Inc. Reports $50.8 Million Revenue and $126.1 Million Net Income in Latest Quarter
Atlanticus Holdings CorpAtlanticus Holdings Reports 41% Revenue Growth to $495.3 Million in Latest Quarter
Apollo Global Management, Inc.Apollo Global Management Reports $1.71 Billion Net Income for Third Quarter 2025